NCT06285058View on ClinicalTrials.gov

Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy

Not yet recruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions

Deep Learning ModelPathological Complete ResponseNon-small Cell Lung CancerNeoadjuvant Chemoimmunotherapy

Interventions

DIAGNOSTIC_TEST

No interventions

The high-throughput extraction of large amounts of quantitative image features from medical images

All Listed Sponsors

lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

NCT06285058 - Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy | Biotech Hunter | Biotech Hunter